Methylene Blue
MB — Mitochondrial Electron Carrier & Cognitive Enhancer
What is Methylene Blue?
Methylene Blue is a synthetic compound with a 130-year history in medicine — originally used as an antimalarial dye, now FDA-approved for methemoglobinemia and vasoplegic syndrome. At low doses (0.5-4 mg/kg), it acts as an alternative mitochondrial electron carrier, improving ATP production efficiency. It has experienced a renaissance in biohacking for cognitive enhancement, neuroprotection, and anti-aging applications.
At low doses, Methylene Blue accepts electrons from NADH and transfers them to cytochrome c, bypassing dysfunctional sections of the mitochondrial electron transport chain and increasing ATP production. It also inhibits monoamine oxidase (MAO) and nitric oxide synthase at higher doses, and has powerful antioxidant activity through its redox cycling between oxidized (blue) and reduced (colorless) forms. It crosses the blood-brain barrier readily and concentrates in mitochondria-rich neurons.
Research Evidence
FDA-approved first-line treatment. Strong efficacy and safety data for this specific indication.
Human studies show low-dose methylene blue improves memory, attention, and cerebral blood flow. MRI studies demonstrate increased brain activation in memory regions.
Multiple animal models show methylene blue protects against Alzheimer's, Parkinson's, and ischemia-related neuronal damage. Human trials for Alzheimer's (as LMTX) are ongoing.
Evidence grades: Gold = RCT human data · Silver = consistent animal/human data · Bronze = limited or preliminary
Dosing Protocols
Reconstitution / Preparation
This compound does not require reconstitution — it is available as an oral or pre-mixed formulation.
Frequently Asked Questions
Is Methylene Blue safe?
At low doses (0.5-4 mg/kg), methylene blue has an excellent safety profile based on 130 years of medical use. The primary concern is serotonin syndrome when combined with serotonergic medications (SSRIs, SNRIs, MAOIs, tramadol). People on any serotonergic medication should not use methylene blue. It is contraindicated in G6PD deficiency.
Does Methylene Blue really improve cognition?
Human evidence is promising. Resting-state fMRI studies show increased brain activation in memory regions with acute low-dose MB. Memory and attention tests show improvements in healthy subjects. The mechanism — improved mitochondrial electron transport in high-energy neurons — is biologically plausible. The cognitive effects appear to follow an inverted U dose-response curve: low doses improve cognition while high doses impair it.
References
- [1]Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol. 2012;96(1):32-45.
- [2]Bhatt S, Bhatt DL, Panza JA, et al. Methylene blue for vasoplegic syndrome in cardiac surgery. Ann Thorac Surg. 2016;101(3):1162-1164.
This profile was prepared using AI-assisted research synthesis. Citations are provided where applicable — verify with primary sources before clinical application.
Share this article